Related Experiment Video
Updated: Jul 20, 2025
05:15
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
123
The Association Between Intra-abdominal Pressure and Diuretic Response in Heart Failure.
S Crespo-Aznarez1,2, A Campos-Sáenz de Santamaría1,2, M Sánchez-Marteles1,2
1Internal Medicine Department, Hospital Clínico Universitario "Lozano Blesa", Avda. San Juan Bosco N° 15, 50009, Zaragoza, Spain.
Current Heart Failure Reports
|July 29, 2023
Summary
Increased intra-abdominal pressure (IAP) in heart failure patients is linked to poorer kidney function and diuretic response. Persistent IAP elevation indicates worse outcomes and impaired prognosis.
Area of Science:
- Cardiology
- Nephrology
- Critical Care Medicine
Background:
- Diuretic efficacy is crucial for managing decompensated heart failure (HF).
- Intra-abdominal pressure (IAP) is increasingly recognized as a factor in cardiorenal syndrome.
- Understanding the IAP-diuretic response relationship can optimize HF management.
Purpose of the Study:
- To review the association between intra-abdominal pressure (IAP) and diuretic response in heart failure (HF) patients.
- To explore IAP's role in cardiorenal syndrome and guiding diuretic therapy during hospitalization.
Main Methods:
- Literature review analyzing studies on IAP, diuretic response, and HF.
- Examination of correlations between IAP levels, renal function, and clinical outcomes in HF patients.
Main Results:
- Elevated IAP correlates with worsening renal function (WRF) in advanced HF.
- Persistent IAP increase after 72 hours of diuretics predicts poor response, high congestion, and worse prognosis.
- Higher IAP is linked to impaired renal function and reduced diuretic efficacy in HF.
Conclusions:
- Increased IAP is associated with adverse outcomes in HF patients.
- Further research is needed to clarify IAP's role in congestive nephropathy and its utility in guiding diuretic therapy for acute decompensations.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
420
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
420
01:16Antihypertensive Drugs: Action of Diuretics
812
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
812
01:30Heart Failure V: Medical Management
13
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
01:29Heart Failure II: Pathophysiology
15
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
744
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
744